Accuracy of Clinical and Diagnostic Studies for Pneumonia in Children

NCT ID: NCT03630380

Last Updated: 2019-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2020-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pneumonia continues to be a leading cause of death in children under five years of age worldwide. Many studies have evaluated clinical signs and symptoms that may predict pneumonia. A recent meta-analysis found that no singular physical exam finding predicted pneumonia. The World Health Organization (WHO) Criteria diagnose pneumonia based on fast breathing; however, tachypnea has not been shown to strongly predict pneumonia. This study will evaluate accuracy of clinical history, physical exam and WHO criteria, laboratory findings, and lung ultrasound compared with chest radiograph for the diagnosis of pneumonia in children under five years of age in a resource limited setting. Determining diagnostic accuracy of these findings may help derive a clinical decision rule that may more accurately predict which children have pneumonia than current WHO guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Pneumonia is the leading cause of death in children under five years of age worldwide.1 These deaths may be prevented by early detection and targeted antibiotic therapy.2 However, the diagnosis is not always clear on presentation to health care facilities. Missed diagnosis may lead to increased morbidity and mortality, while over-diagnosis may lead to unnecessary antibiotic use, which may further lead to increased antibiotic resistance, cause allergic reactions, and create unnecessary costs for patients. Therefore, using clinical tools and diagnostic capabilities to better improve diagnosis is critical.

Many studies have evaluated clinical signs and symptoms that may predict pneumonia.3-6 A recent meta-analysis found that no singular physical exam finding predicted pneumonia.5 The World Health Organization (WHO) Criteria diagnose pneumonia based on fast breathing; however, tachypnea has not been shown to strongly predict pneumonia.7 Additionally, most children with fever have compensatory tachypnea as a result, making the criteria of fast breathing difficult to diagnose pneumonia alone.8 In Nepal, one study evaluating the WHO criteria for pneumonia found a sensitivity of only 69.6% and specificity of 59.6%.9 Despite this, many providers rely on clinical exam findings and the WHO criteria for diagnosing pneumonia.

When available, diagnostic imaging is used regularly to confirm suspected pneumonia. Chest x-ray has been the standard for diagnosis in most facilities worldwide. However, remote facilities in resource-limited settings often lack radiographic imaging capabilities. Many facilities have bedside ultrasound available as it is easily portable, repeatable, and not associated with radiation. Ultrasound has been shown to be sensitive and specific for the diagnosis of pneumonia, yet few studies have evaluated the accuracy of lung ultrasound for pneumonia in pediatric patients in a resource-limited setting.10-14

The objective of this study is to evaluate the diagnostic accuracy of clinical history, physical exam, laboratory findings, and lung ultrasound compared to chest x-ray for the diagnosis of pneumonia in pediatric patients in a resource-limited setting. Determining diagnostic accuracy of these findings may help derive a clinical decision rule that may more accurately predict which children have pneumonia than current WHO guidelines.

Study Design

A prospective observational cross-sectional study of pediatric patients presenting for fever or respiratory complaints to the emergency department and outpatient department at Patan Hospital in Lalitpur, Nepal will be done over one year. Ethical approval will be obtained from the Nepal Health Research Council Ethical Review Board.

Study Setting and Population

Located in the Kathmandu valley, Patan Hospital is a large urban hospital with a 35-bed emergency department. The emergency department has an annual volume of approximately 48,000 patients, including approximately 8,000 pediatric visits. The admission rate is 20%.

Inclusion Criteria: Patients presenting under age 5 years of age with fever, respiratory complaints, or concern for pneumonia and receiving chest x-ray imaging.

Study Protocol

Parents will be consented for inclusion of child in the study (See consent form). Data will be collected on pediatric patients meeting the above inclusion criteria. Data will include demographics (age, gender), duration of symptoms, symptoms (presence or absence of fever, cough, chest pain, difficulty breathing, or vomiting), vital signs (temperature, respiratory rate, oxygen saturation), other physical exam findings (grunting, nasal flaring, retractions or indrawing of chest, crepitations, wheezing, or diminished breath sounds). These will be collected on the data collection form (see Appendix 1). Additionally, white cell counts with neutrophil counts and c-reactive protein will be collected if ordered by the clinician.

As a part of the evaluation, a bedside lung ultrasound will be performed by a clinician trained to perform lung ultrasounds. The bedside lung ultrasound is provided free for patients. Sonographers will be blinded to clinical information and results of any chest imaging. A Sonosite M Turbo (Fujifilm Sonosite, Inc.) ultrasound machine with a curvilinear probe will be used. In accordance with previous literature, the ultrasound examination will include ten views: two anterior views and two lateral views (one including the costophrenic angle), and one posterior view on each hemithorax. The physician will record ultrasound findings and interpretation directly after the ultrasound is complete. An ultrasound diagnosis of pneumonia is defined as the presence of unilateral B lines or subpleural lung consolidation. All ultrasounds will be reviewed for accuracy by a medical sonographer.

All patients will have a single posterioranterior (PA) chest x-ray as a part of the standard evaluation. The chest x-ray will be read by a board-certified radiologist, who is blinded to the clinical presentation and the results of any other imaging. Chest x-ray readings will be recorded on the standardized data form.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Arm

All children under five years of age with clinical suspicion of pneumonia (fever or respiratory complaints) who have a chest radiograph ordered will be consented. Clinical history, physical exam findings (temperature, respiratory rate, oxygen saturation, and lung auscultation findings), laboratory findings (white blood cell count, differential, and CRP) will be recorded. Lung ultrasound will be performed on all patients.

Clinical History

Intervention Type OTHER

We will collect clinical history for each patient (days of illness, history of fever, cough, difficulty breathing, vomiting, chest pain).

Physical Exam Findings

Intervention Type OTHER

We will collect physical exam findings including vital signs, WHO criteria for diagnosing pneumonia, and lung auscultation findings.

Laboratory Findings

Intervention Type OTHER

We will collect laboratory findings (white blood cell counts, differential, and c-reactive protein) if ordered by the clinician.

Lung Ultrasound

Intervention Type OTHER

We will perform lung ultrasound on all patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical History

We will collect clinical history for each patient (days of illness, history of fever, cough, difficulty breathing, vomiting, chest pain).

Intervention Type OTHER

Physical Exam Findings

We will collect physical exam findings including vital signs, WHO criteria for diagnosing pneumonia, and lung auscultation findings.

Intervention Type OTHER

Laboratory Findings

We will collect laboratory findings (white blood cell counts, differential, and c-reactive protein) if ordered by the clinician.

Intervention Type OTHER

Lung Ultrasound

We will perform lung ultrasound on all patients.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients presenting under age 5 years
* Presence of fever, respiratory complaints, or concern for pneumonia
* Receiving chest x-ray imaging

Exclusion Criteria

* Children not receiving chest x-ray imaging as part of their workup for possible pneumonia
* Patients 5 years of age and older
Maximum Eligible Age

59 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Patan Academy of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Darlene Rose House

Assistant Professor of Clinical Emergency Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Darlene R House, MD

Role: PRINCIPAL_INVESTIGATOR

Patan Academy of Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Patan Academy of Health Sciences

Kathmandu, , Nepal

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Nepal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Darlene R House, MD

Role: CONTACT

9810339799

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yogendra Amatya, MDGP

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAHS2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pneumonia Chart Review Cambodia
NCT03260413 WITHDRAWN
Atypical Pneumonia
NCT06727188 NOT_YET_RECRUITING